Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
LT-5001 by LTT Bio-Pharma for Unspecified Neurologic Disorders: Likelihood of Approval
LT-5001 is under clinical development by LTT Bio-Pharma and currently in Phase III for Unspecified Neurologic Disorders. According to GlobalData,...